Nevertheless, considering that atherogenesis is influenced by several risk factors, including comorbidities like obesity and other auto-immune diseases that have been associated with GPR35, our study does not completely rule out its potential relevance for CVDs. This evidence concerns the gene GPR35 and obesity disorder.